Woman Claims Enbrel Maker Allegedly Failed to Warn of Drug's Ability to Cause MS

FORT WORTH, Texas - A woman who allegedly developed multiple sclerosis as a result of using the rheumatoid arthritis drug Enbrel claims the manufacturer of the drug failed to adequately warn consumers of its ability to cause the central nervous system disorder. Randa Hahn v. Amgen, Inc., et al., No. 017-199258-03 (Texas Dist. Ct., Tarrant Cty.).

The suit, filed in the District Court of Tarrant County, Texas, stated that although post-marketing reports involving patients who developed infections and central nervous system disorders started first appearing five months after Enbrel was approved by the FDA in 1998, Amgen, the drug's …